Results 61 to 70 of about 542,903 (199)

Optimising postoperative care after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

open access: yesAdvances in Perioperative Care
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is an aggressive, but increasingly utilised, treatment for advanced peritoneal malignancy.
Laoise Niamh Geoghegan
doaj   +2 more sources

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin

open access: yes, 2009
Maurie MarkmanUniversity of Texas MD Anderson Cancer Center, Houston, Texas, USAAbstract: Both pre-clinical studies and phase 1–2 clinical trials have provided strong support for the potential role of regional drug delivery in the management of
Maurie Markman
core  

Iterative Intraperitoneal Chemotherapy in Gastric Cancer Peritoneal Carcinomatosis. [PDF]

open access: yes
Background/objectives: Despite the incremental improvement of survival with systemic therapy in metastatic gastric cancer (GC), the outcomes of patients with peritoneal carcinomatosis (PC) remain poor.
Maheswari Senthil   +9 more
core   +1 more source

Laparoscopic Hyperthermic Intraperitoneal Chemotherapy plus Neoadjuvant Intraperitoneal and Systemic Chemotherapy for Gastric Cancer with Malignant Ascites

open access: yesJournal of Medical Sciences
Background Patients with gastric cancer (GC) and malignant ascites (MA) usually have poor outcomes and a high risk of recurrence and mortality, even after curative gastrectomy or chemotherapy.
Hsing-Wei Yu   +3 more
doaj   +1 more source

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy

open access: yes, 2012
Daniel L Chan, David L Morris, Archana Rao, Terence C ChuaHepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, and the St George Clinical School, University of New South Wales, St George Hospital, Kogarah, NSW, AustraliaPurpose: To ...
Rao A, Chan DL, Chua TC, Morris DL
core  

Peritoneal chemotherapy delivery systems for ovarian cancer treatment: systematic review of animal models

open access: yesFrontiers in Oncology
IntroductionIntraperitoneal chemotherapy for ovarian cancer treatment has controversial benefits as most methodologies are associated with significant morbidity.
Marcelo Simonsen   +9 more
doaj   +1 more source

Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy

open access: yes, 2012
Hypertermic intraperitoneal chemotherapy is a treatment option after cytorreduction of certain types of malignancies with peritoneal spread. Blistering of the Glisson’s capsule has not been previously reported as a consequence of this treatment modality.
Gabriela Trejo-Gómez   +3 more
core   +1 more source

Intraperitoneal chemotherapy for peritoneal metastases of gastric origin:a systematic review and meta-analysis [PDF]

open access: yes
Background: Gastric cancer with peritoneal metastases is associated with a dismal prognosis. Normothermic catheter-based intraperitoneal chemotherapy and normothermic pressurized intraperitoneal aerosol chemotherapy (PIPAC) are methods to deliver ...
Noordman, Bo J.   +8 more
core   +1 more source

Review: Practical considerations in ovarian cancer chemotherapy

open access: yesTherapeutic Advances in Medical Oncology, 2010
Epithelial ovarian cancer remains the most lethal gynecologic malignancy despite advances in treatment. The standard management generally involves a combination of surgical tumor debulking and chemotherapy.
Mihaela Cristea MD   +3 more
doaj   +1 more source

Prophylactic hyperthermic intraperitoneal chemotherapy can be considered in the management of advanced gastric cancer

open access: yes, 2016
We read with interest the article by Dehal, Smith and Nash (1), intitled “Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review—past, present and future” and, also congratulating them for the comprehensive review performed, we ...
Saladino, Edoardo, MACRI', Antonio
core   +1 more source

Home - About - Disclaimer - Privacy